Early initiation of corticosteroid during immune checkpoint inhibitor treatment may hamper efficacy, according to US and Australian researchers While corticosteroids are commonly used to manage immune-related adverse effects (irAEs), there is uncertainty about their impact on immunotherapy efficacy, they wrote in in the Journal for ImmunoTherapy of Cancer. Their study therefore reviewed survival outcomes and ...
Early corticosteroid use impairs checkpoint inhibitor efficacy
By Natasha Doyle
13 Jul 2021